Immunome, Inc. (IMNM)

Immunome Stock Forecast

Stock Price Forecast

According to 9 professional analysts, the 12-month price target for Immunome stock ranges from a low of $18 to a high of $33. The average analyst price target of $24.89 forecasts a 114.75% increase in the stock price over the next year.

Price Target: $24.89 (+114.75%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$18	$24.89	$25	$33
Change	+55.31%	+114.75%	+115.70%	+184.73%

Analyst Ratings

The average analyst rating for Immunome stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Apr '25	May '25	Jun '25	Jul '25	Aug '25	Sep '25
Strong Buy	2	2	2	2	2	4
Buy	4	4	4	4	5	5
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	7	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Salveen Richter Goldman Sachs	Goldman Sachs	Strong Buy Initiates $26	Strong Buy	Initiates	$26	+124.33%	Sep 22, 2025
Adam Vogel Craig-Hallum	Craig-Hallum	Strong Buy Initiates $26	Strong Buy	Initiates	$26	+124.33%	Sep 5, 2025
Michael Schmidt Guggenheim	Guggenheim	Strong Buy Reiterates $25	Strong Buy	Reiterates	$25	+115.70%	Aug 25, 2025
Cory Kasimov Evercore ISI Group	Evercore ISI Group	Buy Initiates $18	Buy	Initiates	$18	+55.31%	Aug 22, 2025
Brian Cheng JP Morgan	JP Morgan	Buy Maintains $23 → $22	Buy	Maintains	$23 → $22	+89.82%	Aug 7, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

7.07M

Decreased by -21.84%

from 9.04M

Revenue Next Year

18.00M

Increased by 154.70%

from 7.07M

EPS This Year

-2.19

from -5.00

EPS Next Year

-2.38

from -2.19

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	14.02M	9.04M	7.07M	18.00M
Revenue Growth	-	-	-	-	-35.50%	-21.84%	154.70%
EPS	-5.26	-2.14	-3.09	-5.38	-5.00	-2.19	-2.38
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	7.4M	45.2M
Avg	7.1M	18.0M
Low	6.8M	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	-18.7%	539.0%
Avg	-21.8%	154.7%
Low	-25.2%	-

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-1.93	-1.73
Avg	-2.19	-2.38
Low	-2.35	-2.73

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.